{
    "Symbol": "INCY",
    "AssetType": "Common Stock",
    "Name": "Incyte Corporation",
    "Description": "Incyte Corp is an American pharmaceutical company based in Alapocas, Delaware.",
    "CIK": "879169",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TRADE & SERVICES",
    "Industry": "SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH",
    "Address": "1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, US",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-06-30",
    "MarketCapitalization": "12407163000",
    "EBITDA": "124190000",
    "PERatio": "157.12",
    "PEGRatio": "0.695",
    "BookValue": "15.64",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "0.41",
    "RevenuePerShareTTM": "17.32",
    "ProfitMargin": "0.0252",
    "OperatingMarginTTM": "-0.457",
    "ReturnOnAssetsTTM": "0.0039",
    "ReturnOnEquityTTM": "0.0252",
    "RevenueTTM": "3857014000",
    "GrossProfitTTM": "1593729000",
    "DilutedEPSTTM": "0.41",
    "QuarterlyEarningsGrowthYOY": "6.71",
    "QuarterlyRevenueGrowthYOY": "0.093",
    "AnalystTargetPrice": "73.19",
    "AnalystRatingStrongBuy": "8",
    "AnalystRatingBuy": "4",
    "AnalystRatingHold": "13",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "157.12",
    "ForwardPE": "11.39",
    "PriceToSalesRatioTTM": "3.272",
    "PriceToBookRatio": "2.331",
    "EVToRevenue": "2.294",
    "EVToEBITDA": "9.22",
    "Beta": "0.735",
    "52WeekHigh": "70.36",
    "52WeekLow": "50.27",
    "50DayMovingAverage": "61.67",
    "200DayMovingAverage": "58.42",
    "SharesOutstanding": "192598000",
    "DividendDate": "None",
    "ExDividendDate": "None"
}